ROIV technical analysis

ROIV Technical Analysis

Analysis date

August 7, 2026

Market

NasdaqGS (USD)

Daily cutoff

August 5, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

ROIV Data Verification

Checking the latest completed daily bar for date and closing-price consistency before indicators are calculated.

Symbol
ROIV
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
August 5, 2026

Historical prices are adjusted for corporate actions when applicable. Date and closing-price consistency checks passed for the latest completed daily bar.

Validation seriesLatest CloseDateDifferenceStatus
Calculation series34.60August 5, 2026-Verified
Verification series34.60August 5, 20260.00%Verified

Bottom line

ROIV Technical Analysis Summary

ROIV (Roivant Sciences) is in a strong multi-timeframe uptrend, with the stock roughly tripling over the past year. On the daily chart, price at 34.60 trades above SMA50 (32.75) and SMA200 (26.68) and essentially at SMA20 (34.60). The weekly chart is firmly bullish with price above SMA20 (30.61), SMA50 (24.54), and SMA200 (13.75). Short-term momentum has cooled after the run toward the 37.00 high: daily RSI14 at 53.60 and a negative daily MACD histogram at -0.19 reflect a pause rather than a reversal. Key resistance sits at 37.00, which is the 20-day, 60-day, and 52-week high. Immediate support is at SMA20 (34.60), followed by 32.47 (20-day low) and SMA50 (32.75). A decisive break above 37.00 would signal a continuation of the uptrend, while a loss of 32.47 would open a deeper pullback.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (August 5, 2026)

Trend
Bullish. Price at 34.60 is right at SMA20 (34.60) and well above SMA50 (32.75, +5.65%) and SMA200 (26.68, +29.67%). The SMA20 is roughly flat after the recent pullback, while SMA50 and SMA200 continue to slope upward. The longer-term trend is firmly positive, with the stock holding near the top of its 52-week range.
Momentum
Neutral to mildly bullish. RSI14 at 53.60 is above the 50 midline, indicating momentum remains constructive without an overbought reading. The MACD line at 0.24 is below the signal line at 0.42, and the histogram at -0.19 is negative, reflecting a short-term cooling after the advance toward 37.00. This suggests consolidation rather than a fresh breakout at current levels.
Volatility
Moderate. ATR14 at 1.21 is about 3.49% of price, indicating average daily movement near 3.5%. Bollinger Bands from 32.92 to 36.27 show price near the middle band after the pullback from the upper band. Band width is moderate for a mid-cap biotech.
Volume
Above average. Latest volume of 5,854,900 is about 124% of the 20-period average of 4,722,210, showing participation above the recent norm. This is consistent with active trading near the recent high but does not confirm a breakout yet.

Assessment

The daily chart shows a stock in a strong uptrend that has pulled back from its 37.00 high and is consolidating just above SMA20. The longer-term structure remains bullish with price above SMA50 and SMA200, and the 52-week position at 90.8% reflects price near the top of its annual range. The negative daily MACD histogram and RSI just above 50 suggest the recent pause could extend, with SMA20 at 34.60 as the first line of support and 32.47 as the next. A sustained move above 37.00 would be the trigger for continuation.

Weekly (July 27, 2026 week)

Trend
Bullish. Price at 33.91 is above SMA20 (30.61, +10.78%), SMA50 (24.54, +38.16%), and SMA200 (13.75, +146.62%). All three moving averages slope upward, confirming a strong and durable uptrend. The stock has been making higher highs and higher lows across the past year.
Momentum
Bullish. RSI14 at 66.15 is above the 50 midline and approaching overbought territory. The MACD line at 2.93 is above the signal line at 2.81, with a positive histogram of 0.12, keeping weekly momentum in bullish alignment. The reading is consistent with an uptrend that remains intact but is stretched after a large advance.
Volatility
Elevated. ATR14 at 2.22 is about 6.55% of price, reflecting wide weekly ranges for a mid-cap biotech. Bollinger Bands from 24.73 to 36.50 are wide, with price trading near the upper band, consistent with a strong upward trend.
Volume
Slightly below average. Weekly volume of 23,449,200 is about 87% of the 20-week average of 27,009,255. Participation is healthy but not exceptional, and the recent advance has been supported by typical volume.

Assessment

The weekly chart confirms a strong, sustained uptrend with price above all key moving averages and momentum in bullish alignment. RSI at 66.15 shows the trend is strong but approaching overbought, and price sits near the upper Bollinger Band. The stock is trading near the top of its 52-week range at 88.2%. While the trend is clearly constructive, the stretched condition suggests pullbacks are possible within an intact uptrend. A weekly close above 37.00 would extend the advance, while a break below the weekly SMA20 at 30.61 would be the first sign of trend deterioration.

Key indicators

ROIV Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)53.6066.15
MACD (12, 26, 9)0.24 / 0.42 / -0.192.93 / 2.81 / 0.12
ATR (14)1.21 (3.49%)2.22 (6.55%)
Bollinger Bands (20, 2)32.92 - 36.2724.73 - 36.50
SMA (20)34.6030.61
SMA (50)32.7524.54
SMA (200)26.6813.75

Price structure

ROIV Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price34.6033.91
1-Period Return+0.03%-3.14%
5-Period Return+5.26%-0.47%
20-Period Return-4.13%+20.85%
60-Period Return+21.15%+201.96%
252-Period Return+200.61%+262.67%
52-Week Low10.9010.90
52-Week High37.0037.00
52-Week Position90.80%88.16%

Key levels

ROIV Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High37.0037.00
20-Period Low32.4725.95
60-Period High37.0037.00
60-Period Low27.8510.71

Scenarios

ROIV Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

A daily close above 37.00 on above-average volume, breaking the 20-day, 60-day, and 52-week high and extending the uptrend.

Invalidation

Price falls back below SMA20 (34.60) and breaks the 20-day low at 32.47.

What to watch

Daily RSI holding above 50; daily MACD histogram turning positive; volume expanding on the breakout; weekly MACD staying above its signal line.

Range-Bound

Trigger

Price oscillates between support at 32.47 (20-day low) and resistance at 37.00 (recent high) while the stock consolidates its large advance.

Invalidation

A decisive break above 37.00 or below 32.47 with increasing volume.

What to watch

RSI staying between 45 and 65; the daily MACD histogram narrowing toward zero; volume staying near average levels.

Bearish

Trigger

Price fails to hold SMA20 (34.60) and breaks below 32.47, opening a deeper pullback toward the 60-day low at 27.85 or the weekly SMA20 at 30.61.

Invalidation

Price reclaims and holds above SMA20 (34.60) and recovers toward the 37.00 high.

What to watch

Daily RSI falling below 50; the daily MACD histogram deepening further negative; weekly RSI turning down from overbought; volume rising on down days.

Methodology

Methodology and Limitations

This technical analysis is calculated locally from adjusted OHLCV history. The daily series ends August 5, 2026, and the weekly series ends July 27, 2026 week. The latest completed daily bar is independently checked for date and closing-price consistency. Historical prices are adjusted for corporate actions when applicable. Indicators include Wilder RSI(14), MACD(12,26,9), SMA20/50/200, Wilder ATR(14), Bollinger Bands(20,2), relative volume, multi-period returns, and price-range levels. Support and resistance are descriptive zones, not guaranteed reversal points. Historical patterns do not predict future prices, and this page is not investment advice.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Market data is checked for date and closing-price consistency before indicators are calculated. Data cutoffs: daily August 5, 2026, weekly July 27, 2026 week. Generated August 7, 2026.